fda tirzepatide obesity Huge news: has approved Zepbound (tirzepatide- GLP-1/GIP receptor agonist) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity. As a cardiologist, this is a huge deal FDA approves Zepbound for chronic

However, as with all medications, Wegovy carries potential side effects that require careful monitoring, including questions about its impact on mental health and psychological wellbeing

For best results, use for 60 days in combination with diet and exercise

Mineral Blend: Includes magnesium, zinc, manganese, and copper and is intended for IM injection or IV infusion only

With the patent expiry of semaglutide in emerging markets

Lilly issued it own alert in June on the dangers of compounded tirzepatide, noting that it is the "only lawful supplier of FDA-approved tirzepatide medicines." "Lilly is deeply concerned about the proliferation of online sales and posts on social media involving counterfeit, fake, compounded and any other unsafe or untested versions of what they say is tirzepatide," the company said